Literature DB >> 11982701

Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas.

Nirmitha I Herath1, Michael C Kew, Michael D Walsh, Joanne Young, Lawrie W Powell, Barbara A Leggett, Graeme A MacDonald.   

Abstract

Chromosome 9p21, a locus comprising the tumor suppressor genes (TSG) p16(INK4a) and p14(ARF), is a common region of loss of heterozygosity (LOH) in hepatocellular carcinoma (HCC). p14(ARF) shares exon 2 with p16 in a different reading frame. p14 binds to MDM2 resulting in a stabilization of functional p53. This study examined the roles of p14, p16 and p53 in hepatocarcinogenesis, in 37 Australian and 24 South African patients. LOH at 9p21 and 17p13.1, p14 and p16 mutation analysis, p14 and p16 promoter methylation and p14, p16 and p53 protein expression was examined. LOH at 9p21 was detected more frequently in South African HCC (P = 0.04). Comparable rates of p53 LOH were observed in Australian and South African HCC (10/22, 45%vs 13/22, 59%, respectively). Hypermethylation of the p14 promoter was more prevalent in Australian HCC than in South African HCC (17/37, 46%vs 7/24, 29%, respectively). In Australian HCC the prevalence of p14 methylation increased with age (P = 0.03). p16 promoter methylation was observed in 12/37 (32%) and 6/24 (25%) in Australian and South African HCC, respectively. Loss of p16 protein expression was detected in 14/36 Australian HCC whereas p53 protein expression was detected in 9/36. Significantly, a reciprocal relationship between 9p21 LOH and p14 promoter hypermethylation was observed (P < or = 0.05). No significant association between p14 and p53 was seen in this study. The reciprocal relationship identified indicates different pathways of tumorigenesis and likely reflects different etiologies of HCC in the two countries. Copyright 2002 Blackwell Science Asia Pty Ltd

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982701     DOI: 10.1046/j.1440-1746.2002.02704.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.

Authors:  Xiaoying Zhang; Hiu Ming Li; Zhiyan Liu; Gengyin Zhou; Qinghui Zhang; Tingguo Zhang; Jianping Zhang; Cuijuan Zhang
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

2.  Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).

Authors:  Georgi Kirovski; Axel P Stevens; Barbara Czech; Katja Dettmer; Thomas S Weiss; Peter Wild; Arndt Hartmann; Anja K Bosserhoff; Peter J Oefner; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2011-01-28       Impact factor: 4.307

3.  Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma.

Authors:  Guang-Neng Zhu; Li Zuo; Qing Zhou; Su-Mei Zhang; Hua-Qing Zhu; Shu-Yu Gui; Yuan Wang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma.

Authors:  Radoslav Davidović; Jelena Sopta; Vesna Mandušić; Milena Krajnović; Maja Stanojević; Goran Tulić; Bogomir Dimitrijević
Journal:  Med Oncol       Date:  2013-08-06       Impact factor: 3.064

5.  Effects of p16 gene on biological behaviours in hepatocellular carcinoma cells.

Authors:  Jian-Zhao Huang; Sui-Sheng Xia; Qi-Fa Ye; Han-Ying Jiang; Zhong-Hua Chen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.